Pricing Log in Create free account

GENPREX (GNPX) vs Trevena, Inc. (TRVN)

GENPREX and Trevena, Inc. are both Biotechnology companies. GENPREX and Trevena, Inc. are of similar size ($1.9M and $1.8M). Trevena, Inc. has negative trailing earnings, so its P/E is not meaningful; GENPREX trades at 0.0×. GENPREX has the higher net margin (0.00% vs −6,233.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, GENPREX leads on 7 and Trevena, Inc. on 5.

Valuation

Metric GNPX TRVN Biotechnology median
P/E 0.03 n/m 8.50
P/S n/m n/m 9.71
P/B 0.07 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.89 n/m 0.64
EV/Sales n/m 35.04 9.21
Earnings yield 3,170.61% 0.00% (33.15%)
Free cash flow yield (1,481.72%) 0.00% (25.50%)

Profitability

Metric GNPX TRVN Biotechnology median
Gross margin 0.00% (190.29%) 65.16%
Operating margin 0.00% (5,879.85%) 0.00%
Net margin 0.00% (6,233.70%) 0.00%
Free cash flow margin 0.00% (4,961.72%) 0.00%
Return on equity (203.86%) 344.49% (56.36%)
Return on assets (157.40%) (105.83%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GNPX TRVN Biotechnology median
Revenue growth (TTM) — (82.97%) 6.02%
EPS growth (last fiscal year) 93.48% 58.37% 30.26%
Revenue growth, 5-year CAGR — (11.43%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GNPX TRVN Biotechnology median
Debt to equity 0.00 (1.41) 0.00
Current ratio 6.76 2.42 4.72
Net debt to EBITDA 0.50 0.06 0.96

Dividend

Metric GNPX TRVN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GNPX TRVN Biotechnology median
Market cap 1.88m 1.81m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack